These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34689805)

  • 1. The effect of opioids on gastrointestinal function in the ICU.
    Yan Y; Chen Y; Zhang X
    Crit Care; 2021 Oct; 25(1):370. PubMed ID: 34689805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From dysmotility to virulent pathogens: implications of opioid use in the ICU.
    Chapple LA; Deane A
    Curr Opin Crit Care; 2018 Apr; 24(2):118-123. PubMed ID: 29461261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal Motility Disorders Correlate with Intracranial Bleeding, Opioid Use, and Brainstem Edema in Neurosurgical Patients.
    Kunovac F; Cicvaric A; Robba C; Turk T; Muzevic D; Kralik K; Kvolik S
    Neurocrit Care; 2023 Oct; 39(2):368-377. PubMed ID: 36788178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-induced bowel dysfunction.
    Thomas J
    J Pain Symptom Manage; 2008 Jan; 35(1):103-13. PubMed ID: 17981003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain management principles in the critically ill.
    Erstad BL; Puntillo K; Gilbert HC; Grap MJ; Li D; Medina J; Mularski RA; Pasero C; Varkey B; Sessler CN
    Chest; 2009 Apr; 135(4):1075-1086. PubMed ID: 19349403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal Dysmotility in Critically Ill Patients: Bridging the Gap Between Evidence and Common Misconceptions.
    Salamone S; Liu R; Staller K
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):440-450. PubMed ID: 36227004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction.
    Leppert W
    Drug Des Devel Ther; 2015; 9():2215-31. PubMed ID: 25931815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec.
    Williams RE; Bosnic N; Sweeney CT; Duncan AW; Levine KB; Brogan M; Cook SF
    Pain Res Manag; 2008; 13(5):395-400. PubMed ID: 18958311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal Motility Disorders in Critically Ill.
    Govil D; Pal D
    Indian J Crit Care Med; 2020 Sep; 24(Suppl 4):S179-S182. PubMed ID: 33354038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempts to Limit Opioid Prescribing in Critically Ill Patients: Not So Easy, Not So Fast.
    Erstad BL
    Ann Pharmacother; 2019 Jul; 53(7):716-725. PubMed ID: 30638027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered GI motility in critically Ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach.
    Ukleja A
    Nutr Clin Pract; 2010 Feb; 25(1):16-25. PubMed ID: 20130154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motility disorders of the upper gastrointestinal tract in the intensive care unit: pathophysiology and contemporary management.
    Stupak DP; Abdelsayed GG; Soloway GN
    J Clin Gastroenterol; 2012 Jul; 46(6):449-56. PubMed ID: 22469641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal motility problems in critical care: a clinical perspective.
    Adike A; Quigley EM
    J Dig Dis; 2014 Jul; 15(7):335-44. PubMed ID: 24673805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory effects of opioids and implications for intensive care unit populations.
    Mefford B; Donaldson JC; Bissell BD
    Pharmacotherapy; 2021 Aug; 41(8):668-675. PubMed ID: 34129683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature review.
    Boswell K; Kwong WJ; Kavanagh S
    J Opioid Manag; 2010; 6(4):269-89. PubMed ID: 20862907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Opioids for Pain Management in Adult Critically Ill Patients.
    Wampole CR; Smith KE
    J Pharm Pract; 2019 Jun; 32(3):256-270. PubMed ID: 30845871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine.
    Reintam Blaser A; Preiser JC; Fruhwald S; Wilmer A; Wernerman J; Benstoem C; Casaer MP; Starkopf J; van Zanten A; Rooyackers O; Jakob SM; Loudet CI; Bear DE; Elke G; Kott M; Lautenschläger I; Schäper J; Gunst J; Stoppe C; Nobile L; Fuhrmann V; Berger MM; Oudemans-van Straaten HM; Arabi YM; Deane AM;
    Crit Care; 2020 May; 24(1):224. PubMed ID: 32414423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrition and Gastrointestinal Dysmotility in Critically Ill Burn Patients: A Retrospective Observational Study.
    Sierp EL; Kurmis R; Lange K; Yandell R; Chapman M; Greenwood J; Chapple LS
    JPEN J Parenter Enteral Nutr; 2021 Jul; 45(5):1052-1060. PubMed ID: 32767430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.
    Sawh SB; Selvaraj IP; Danga A; Cotton AL; Moss J; Patel PB
    Mayo Clin Proc; 2012 Mar; 87(3):255-9. PubMed ID: 22386181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional strategies during gastrointestinal dysfunction.
    van Gassel RJJ; Bels JLM; van de Poll MCG
    Curr Opin Crit Care; 2023 Aug; 29(4):354-359. PubMed ID: 37338807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.